Viking Therapeutics is led by Dr. Brian Lian, who serves as the President, Chief Executive Officer, and a member of the Board of Directors. Before taking the helm at Viking, he built a robust career in life sciences as a managing director and senior biotechnology equity research analyst covering small- and mid-cap therapeutic firms, and earlier worked as a research scientist specializing in small-molecule drug discovery. Under his leadership, the company has advanced prominent clinical pipelines targeting metabolic and endocrine disorders.